An ROR1 bi-specific T-cell engager provides effective targeting and cytotoxicity against a range of solid tumors (OncoImmunology, 2017)

(untitled) - Gohil, S; Paredes-Moscosso, S; Harrasser, M; Vezzalini, M; Scarpa, A; Morris, E; Davidoff, A; Sorio, C; Nathwani, A; Della Peruta, M